Stock Pick

Stocks on the Move: Biogen on FDA approval of Alzheimer’s drug; Illumina revenue down 25% due to the pandemic


Written by

therawinformant

in

Stocks on the Move: Biogen on FDA approval of Alzheimer's drug; Illumina revenue down 25% due to the pandemic
Yahoo Finance’s On the Move panel discuss today’s Stocks on the Move; Biogen and Illumina.

from Yahoo Finance https://ift.tt/3a4lANz

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

More posts